Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Translational Control of Anabolic Resistance in Aging Muscle: Complete Statistical AnalysisIndependent statistical analysis of Translational Control of Anabolic Resistance in Aging Muscle: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03839628).
- Translational Development of Photon-counting CT Imaging: Complete Statistical AnalysisIndependent statistical analysis of Translational Development of Photon-counting CT Imaging: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03878134).
- Transmagnetic Stimulation Pilot in Early Stage Alzheimer’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Transmagnetic Stimulation Pilot in Early Stage Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05292222).
- Transnasal Cooling for Migraine: Complete Statistical AnalysisIndependent statistical analysis of Transnasal Cooling for Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04936061).
- Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Laser Laryngeal Surgery: Complete Statistical AnalysisIndependent statistical analysis of Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) and Laser Laryngeal Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03086265).
- Transplant LADIndependent statistical analysis of Kidney Transplant Low-AGE Diet Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05104242).
- TransPRKCXLIndependent statistical analysis of Simultaneous TransPRK and Corneal Collagen Cross-Linking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02208089).
- Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Transrectal MRI-Guided Biopsy in Identifying Cancer in Patients With Suspected Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Transurethral Ultrasonic Imaging For Detection and Classification of Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Transurethral Ultrasonic Imaging For Detection and Classification of Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02307552).
- Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia After Laparoscopic Colonic Resection: Complete Statistical AnalysisIndependent statistical analysis of Transversus Abdominis Plane (TAP) Block for Postoperative Analgesia After Laparoscopic Colonic Resection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA: Complete Statistical AnalysisIndependent statistical analysis of Transversus Abdominis Plane Block in Microsurgical Breast Recon w/Abdominal Free Flap in Breast CA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery: Complete Statistical AnalysisIndependent statistical analysis of Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TraP-AFIndependent statistical analysis of Tragus Stimulation to Prevent Atrial Fibrillation After Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03392649).
- Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients: Complete Statistical AnalysisIndependent statistical analysis of Trastuzumab (Herceptin), Bevacizumab, and Docetaxel (Taxotere) Trial in Stage IV Metastatic Breast Cancer (MBC) Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trastuzumab and Ixabepilone in Treating Women With HER2-Positive Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Trastuzumab Deruxtecan (DS-8201a) Versus Investigator’s Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]: Complete Statistical AnalysisIndependent statistical analysis of Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]: primary endpoint results, effect estimate with confidence interval, sample-size…
- Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trastuzumab Deruxtecan (T-DXd) Alone or in Sequence With THP, Versus Standard Treatment (ddAC-THP), in HER2-positive Early Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trastuzumab, Cyclophosphamide, and an Allogeneic GM-CSF-secreting Breast Tumor Vaccine for the Treatment of HER-2/Neu-Overexpressing Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Traumatic Brain Injury and Risk for Chronic Traumatic Encephalopathy: Complete Statistical AnalysisIndependent statistical analysis of Traumatic Brain Injury and Risk for Chronic Traumatic Encephalopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02003183).
- Traveler’s Diarrhea (TD) Automated Process: Complete Statistical AnalysisIndependent statistical analysis of Traveler's Diarrhea (TD) Automated Process: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00751777).
- TravelingTESIndependent statistical analysis of Traveling-wave Transcranial Electric Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05399381).
- TRAXHER2Independent statistical analysis of A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric…
- TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma: Complete Statistical AnalysisIndependent statistical analysis of TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Treadmill Cardiovascular Safety Study of Erenumab (AMG 334): Complete Statistical AnalysisIndependent statistical analysis of Treadmill Cardiovascular Safety Study of Erenumab (AMG 334): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02575833).
- Treadmill Training and Orthotic Use in Infants With Down Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Treadmill Training and Orthotic Use in Infants With Down Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00825175).
- Treat & TrainIndependent statistical analysis of A Post-Marketing-Observational Study (PMOS) to Determine the Effectiveness of Combined Adalimumab Treatment and Active Supervised Training in Patients With Axial Spondyloarthritis (axSpA): primary endpoint results, effect estimate with…
- Treat COVID-19 Patients With Regadenoson: Complete Statistical AnalysisIndependent statistical analysis of Treat COVID-19 Patients With Regadenoson: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04606069).
- Treating Acutely Agitated Patients With Asenapine Sublingual Tablets: Complete Statistical AnalysisIndependent statistical analysis of Treating Acutely Agitated Patients With Asenapine Sublingual Tablets: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01400113).
- Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators: Complete Statistical AnalysisIndependent statistical analysis of Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02809677).
- Treating Chronic Insomnia in Breast Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Treating Chronic Insomnia in Breast Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00337272).
- Treating Civilian Traumatic Brain Injury With High Definition Transcranial Direct Current Stimulation (ciTBI-HDtDCS): Complete Statistical AnalysisIndependent statistical analysis of Treating Civilian Traumatic Brain Injury With High Definition Transcranial Direct Current Stimulation (ciTBI-HDtDCS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Treating COVID-19 With Hydroxychloroquine (TEACH): Complete Statistical AnalysisIndependent statistical analysis of Treating COVID-19 With Hydroxychloroquine (TEACH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04369742).
- Treating H. Pylori in Parkinson’s Patients With Motor Fluctuations: Complete Statistical AnalysisIndependent statistical analysis of Treating H. Pylori in Parkinson's Patients With Motor Fluctuations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00664209).
- Treating Hearing Loss to Improve Mood and Cognition in Older Adults: Complete Statistical AnalysisIndependent statistical analysis of Treating Hearing Loss to Improve Mood and Cognition in Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients: Complete Statistical AnalysisIndependent statistical analysis of Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Treating Low-Income Smokers in the Hospital Emergency Department: Complete Statistical AnalysisIndependent statistical analysis of Treating Low-Income Smokers in the Hospital Emergency Department: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01328431).
- Treating Non-epileptic Seizures Using Magnetic Brain Stimulation: Complete Statistical AnalysisIndependent statistical analysis of Treating Non-epileptic Seizures Using Magnetic Brain Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02796924).
- Treating Nonalcoholic Steatohepatitis With Pioglitazone: Complete Statistical AnalysisIndependent statistical analysis of Treating Nonalcoholic Steatohepatitis With Pioglitazone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00062764).
- Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy: Complete Statistical AnalysisIndependent statistical analysis of Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Treating Phobia With Multivoxel Neuro-reinforcement: Complete Statistical AnalysisIndependent statistical analysis of Treating Phobia With Multivoxel Neuro-reinforcement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03655262).
- Treating Primary Progressive Aphasia (PPA) Using tDCS: Complete Statistical AnalysisIndependent statistical analysis of Treating Primary Progressive Aphasia (PPA) Using tDCS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04566731).
- Treating Violence-Prone Substance Use Disorder Patients: Complete Statistical AnalysisIndependent statistical analysis of Treating Violence-Prone Substance Use Disorder Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00700973).
- Treatment for Adolescent Marijuana Abuse: Complete Statistical AnalysisIndependent statistical analysis of Treatment for Adolescent Marijuana Abuse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00580671).
- Treatment for Cannabis Withdrawal and Dependence: Complete Statistical AnalysisIndependent statistical analysis of Treatment for Cannabis Withdrawal and Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01611948).
- Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E: Complete Statistical AnalysisIndependent statistical analysis of Treatment for Non-Alcoholic Fatty Liver With Different Doses of Vitamin E: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay: Complete Statistical AnalysisIndependent statistical analysis of Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Treatment Intensity – Apraxia of Speech: Complete Statistical AnalysisIndependent statistical analysis of Treatment Intensity - Apraxia of Speech: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02332915).
- Treatment Modification to Reduce Symptom Burden in Hemodialysis: Complete Statistical AnalysisIndependent statistical analysis of Treatment Modification to Reduce Symptom Burden in Hemodialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01775800).